None listed
Conditions
Brief summary
Medicinal cannabis has recently become available under prescription for the treatment of a range of intractable diseases. The efficacy of medicinal cannabis has not been tested in the general practice setting. We will test the hypothesis that specific formulations of medicinal cannabis will provide partial or complete symptom relief of at least one intractable disease..
Interventions
Treatment with medicinal cannabis.
Patients attending our general practice, who are prescribed medicinal cannabis by our authorised practitioner, will be asked to complete a questionnaire (PROMIS 29) every three months for a total time commitment of 4 h snd five mins over the 12-month treatment period. The questionnaire allows the practitioner to quantify the efficacy of the treatment for individual patients. With the patients' permission, we will pool anonymised PROMIS29 responses from like-tre
Treatment with medicinal cannabis. Patients attending our general practice, who are prescribed medicinal cannabis by our authorised practitioner, will be asked to complete a questionnaire (PROMIS 29) every three months for a total time commitment of 4 h snd five mins over the 12-month treatment period. The questionnaire allows the practitioner to quantify the efficacy of the treatment for individual patients. With the patients' permission, we will pool anonymised PROMIS29 responses from like-treated individuals that will provide a statistically-relevant measure of drug potency. It is important to note that patients will be treated with medicinal cannabis regardless of their agreement to be involved in the study.
Sponsors
Precision Pharmaceuticals Pty Ltd
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
This study aims to examine the effect of cannabis formulations in patients with intractable chronic disease of any cause. Participants must be: 18 years of age or over Under the care of a physician for treatment of an intractable disease Willing to take medicinal cannabis Willing to share personal data
Exclusion criteria
Healthy individuals Less than 18 years of age Suffering from an acute disease Unwilling to take medicinal cannabis Unwilling to share personal data
Outcome results
None listed